Webcasts

Automated High Throughput SEC Native Mass Spectrometry for mAb Screening

Thursday, September 22nd, 2022 9:00am EDT|6:00am PDT|2:00pm BST|3:00pm CEST 2:00pm EDT|11:00am PDT|7:00pm BST|8:00pm CEST See how RapidFire automated size exclusion chromatography (SEC) combined with the power of ion mobility mass spectrometry (IM-MS) enables efficient biotherapeutic development.

Stem Cell Derived Exosome Production in Stirred-Tank Bioreactors

Thursday, September 15th, 2022 at 4pm CEST | 3pm BST | 10am EDT Extra cellular vesicles and especially exosomes have recently gained favor for therapeutic medicine development due to possessing structures that can be modified to conveniently deliver payloads, such as specific proteins, genetic lipids, and genetic materials including messenger RNA (mRNA, and genomic DNA (gDNA) from their progenitor cell. Most recently, there is increasing interest in the therapeutic potential of exosomes produced by Mesenchymal Stem Cells (MSCs). Stirred-tank bioreactors offer the possibility to tightly control and monitor the production of exosomes, as well as the scalability, to produce increasing amounts. However, the cultivation of stem cells in stirred-tank bioreactors requires profound knowledge and precise control of the process.

Automating Image Analysis with Deep Learning

Tue, Sep 13, 2022 10:00 AM EDT Discover how AstraZeneca uses Genedata Imagence—an enterprise-scale, deep learning-based software solution for image analysis—for projects spanning different disease areas and stages of R&D

Developing GMP-Manufactured Cas9 Proteins for Therapeutic Applications

Thursday, June 30, 2022 at 11am PST | 1pm CST | 2pm EST As CRISPR based gene editing progresses from research to therapeutic applications, there is a growing need for high quality GMP grade materials, including the Cas9 protein and supporting instruments, and to minimize off target events. This webinar will discuss the development process of a GMP-manufactured Cas9 protein along with causes of off target events and how to minimize risk with high fidelity Cas9 protein.

  GMP Biomanufacturing solutions: Walk the halls of Getinge Applikon following a stainless steel Project

Monday June 20th, 2022 at 11am ET | 10am CT | 8am PT Getinge Applikon invites you to get a glimpse of a process for stainless steel bioreactor manufacturing and verification. Walk through the halls of our manufacturing facility and see how commercial scale stainless steel vessels take shape, get to know Getinge engineers, visit manufacturing stages, and hear how the experts collaborate to configure and fabricate a system for manufacturing.

Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use

Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.

Plan Now or Fail Later: Why raw materials matter

Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..

Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization

Tuesday, April 12th 2022 at 10 am EDT | 7 am PDT | 3 pm GMT Freezing and thawing biotherapeutics requires experienced leadership to navigate material and instrument selection as well as quality, space, regulatory and other considerations in creating a new cold-chain ecosystem. This webinar discusses the design of processes in partnership with a uniquely resourced freeze/thaw technology center.

Oligonucleotide Purification and Characterization - Tips for Success

Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.

Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries

Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.

Managing Growth During Covid: A Supply Chain Perspective

This webcast is now available on demand! The delicate dance between strategic initiatives of continuous improvement and maintaining daily operational discipline amid the significant challenges placed on global supply chains by COVID-19. This webcast will discuss the risk-based approach used to minimize procurement risk and optimize material readiness.

Methodology Development for Complete Nucleoside and Nucleotide Monitoring within Cell Samples

Tuesday, February 8th, 2022 at 9am EST | 3pm CET | 2pm GMT and 2pm EST | 11am PST | 7pm GMT Approaches and lessons learned on developing an HPLC methodology to cover a complex and broad range of polar analytes: the complete cellular pool of nucleosides and nucleotides plus our drug candidates and associated prodrugs. The utility of PEEK-lined columns and newer HILIC-Z column phases is highlighted in this anecdote of HPLC methodology development.

Wednesday, February 8th at 11am EST | 10am CST | 8am PST Industry shifts in container closure integrity (CCI) are driving the next generation of quality control solutions. Understanding the physics behind the technologies and their relation to your application will carve a path of successful CCI assurance.